INSIGHTS ON DRUG DEVELOPMENT

• Direct API Capsule Filling: A Faster Path To Market

  Direct API capsule filling eliminates complex formulation steps, leveraging volumetric drum dosing and 100% net weight verification to accelerate drug development timeline efficiency.

• A Novel Patient-Derived Colorectal Cancer Organoid Platform

  Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.

• Comprehensive Workflow For The Quantification Of Peptides And Proteins

  Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.

• Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity

  Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.

• The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly

  3/3/2025

  In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

• Tablet Edge Erosion – Solutions For Friability

  11/11/2024

  Addressing tablet edge erosion and friability involves adjusting formulation, tablet design, tooling, press setup, and operation speed to improve tablet robustness and reduce weight loss.

• Managing The Challenges Of Controlled Substance Manufacturing

  9/22/2026

  How can manufacturers balance security, compliance, and supply continuity in controlled substance development and production?

• Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications

  8/31/2026

  More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.

• CRISPR Meets LNPs: A New Era In Cell And Gene Therapies

  7/8/2025

  Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.